CIK 0000925741 · Non-accelerated filer<br>Smaller reporting company
BioCardia, Inc.
Sign in to watch- Ticker
- BCDA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 232753988
- Phone
- 650-226-0123
- Business address
- 320 SOQUEL WAY, SUNNYVALE, CA, 94085
- Former names
- Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
- Open-market buys, last 90 days
- $9,394
- in 5 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,394. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-21 | Altman Peter President and CEO | Purchase | +400 | $1.23 | $492 | 275,766 |
| 2026-04-20 | Altman Peter President and CEO | Purchase | +600 | $1.23 | $738 | 275,366 |
| 2026-03-25 | Altman Peter President and CEO | Purchase | +300 | $1.22 | $366 | 274,766 |
| 2026-03-24 | Altman Peter President and CEO | Purchase | +600 | $1.24 | $744 | 274,466 |
| 2026-02-04 | Altman Peter President and CEO | Purchase | +5,000 | $1.13 | $6K | 273,866 |
| 2026-01-21 | Altman Peter President and CEO | Purchase | +300 | $1.34 | $402 | 268,866 |
| 2026-01-20 | Altman Peter President and CEO | Purchase | +600 | $1.32 | $792 | 268,566 |
| 2025-12-17 | Altman Peter President and CEO | Purchase | +900 | $1.30 | $1K | 267,966 |
| 2025-12-16 | Altman Peter President and CEO | Purchase | +200 | $1.37 | $274 | 267,066 |
| 2025-12-08 | Altman Peter President and CEO | Grant or award | +106,588 | $1.37 | $146K | 323,350 |
| 2025-12-08 | Altman Peter President and CEO | Shares withheld for taxes | +56,484 | $1.37 | $77K | 266,866 |
| 2025-12-08 | Altman Peter President and CEO | Grant or award · Stock Option (right to buy) | +38,000 | 90,215 | ||
| 2025-12-08 | McClung David Chief Financial Officer | Grant or award | +58,276 | $1.37 | $80K | 106,226 |
| 2025-12-08 | McClung David Chief Financial Officer | Shares withheld for taxes | +29,339 | $1.37 | $40K | 76,887 |
| 2025-12-08 | McClung David Chief Financial Officer | Grant or award · Stock Option (right to buy) | +27,000 | 46,340 | ||
| 2025-12-08 | GILLIS EDWARD M Senior Vice President, Devices | Grant or award | +38,078 | $1.37 | $52K | 47,046 |
| 2025-12-08 | GILLIS EDWARD M Senior Vice President, Devices | Shares withheld for taxes | +15,172 | $1.37 | $21K | 31,874 |
| 2025-12-08 | GILLIS EDWARD M Senior Vice President, Devices | Grant or award · Stock Option (right to buy) | +20,000 | 31,697 | ||
| 2025-12-08 | Allen Jim L. Director | Grant or award · Stock Option (right to buy) | +12,000 | 15,313 | ||
| 2025-12-08 | MOYES JAY M Director | Grant or award · Stock Option (right to buy) | +12,000 | 15,573 |
Page 3 of 14 · 273 trades